These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 33099540)

  • 1. CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer.
    Cui Y; Song Y; Yan S; Cao M; Huang J; Jia D; Liu Y; Zhang S; Fan W; Cai L; Li C; Xing Y
    Aging (Albany NY); 2020 Oct; 12(20):20047-20068. PubMed ID: 33099540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA‑133b targets TGFβ receptor I to inhibit TGF‑β‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑β/SMAD pathway in breast cancer.
    Wang S; Huang M; Wang Z; Wang W; Zhang Z; Qu S; Liu C
    Int J Oncol; 2019 Nov; 55(5):1097-1109. PubMed ID: 31545407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway.
    Li WQ; Zhang JP; Wang YY; Li XZ; Sun L
    Cell Cycle; 2019 Aug; 18(15):1727-1744. PubMed ID: 31204561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor.
    Park SJ; Choi YS; Lee S; Lee YJ; Hong S; Han S; Kim BC
    Cancer Lett; 2016 Oct; 381(2):314-22. PubMed ID: 27543359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Wilms' Tumor Proliferation and Invasion by Blocking TGF-
    Shi Q; Wu H; Li Y; Shen L; Tian X; Lin T; Wei G
    Biomed Res Int; 2020; 2020():8039840. PubMed ID: 33282954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling.
    Lu Z; Li Y; Che Y; Huang J; Sun S; Mao S; Lei Y; Li N; Sun N; He J
    Cancer Lett; 2018 Sep; 432():156-168. PubMed ID: 29908210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway.
    Chen W; Zhang Y; Fang Z; Qi W; Xu Y
    Cytokine; 2022 May; 153():155831. PubMed ID: 35301175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA LITATS1 suppresses TGF-β-induced EMT and cancer cell plasticity by potentiating TβRI degradation.
    Fan C; Wang Q; Kuipers TB; Cats D; Iyengar PV; Hagenaars SC; Mesker WE; Devilee P; Tollenaar RAEM; Mei H; Ten Dijke P
    EMBO J; 2023 May; 42(10):e112806. PubMed ID: 36994542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway.
    Wu D; Zhao B; Qi X; Peng F; Fu H; Chi X; Miao QR; Shao S
    Cancer Lett; 2018 Apr; 418():135-146. PubMed ID: 29331415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer.
    Wang B; Tang Z; Gong H; Zhu L; Liu X
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nannocystin Ax, a natural elongation factor 1α inhibitor from Nannocystis sp., suppresses epithelial-mesenchymal transition, adhesion and migration in lung cancer cells.
    Sun C; Liu R; Xia M; Hou Y; Wang X; Lu JJ; Liu B; Chen X
    Toxicol Appl Pharmacol; 2021 Jun; 420():115535. PubMed ID: 33848516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer.
    Huo W; Zhu XM; Pan XY; Du M; Sun Z; Li ZM
    Math Biosci Eng; 2019 May; 16(5):4607-4621. PubMed ID: 31499680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLEK2 mediates metastasis and vascular invasion via the ubiquitin-dependent degradation of SHIP2 in non-small cell lung cancer.
    Wu DM; Deng SH; Zhou J; Han R; Liu T; Zhang T; Li J; Chen JP; Xu Y
    Int J Cancer; 2020 May; 146(9):2563-2575. PubMed ID: 31498891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTPL1 suppresses lung cancer cell migration via inhibiting TGF-β1-induced activation of p38 MAPK and Smad 2/3 pathways and EMT.
    Zhu N; Zhang XJ; Zou H; Zhang YY; Xia JW; Zhang P; Zhang YZ; Li J; Dong L; Wumaier G; Li SQ
    Acta Pharmacol Sin; 2021 Aug; 42(8):1280-1287. PubMed ID: 33536603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.
    Xing Y; Meng Q; Chen X; Zhao Y; Liu W; Hu J; Xue F; Wang X; Cai L
    Oncotarget; 2016 May; 7(21):30479-91. PubMed ID: 27058415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ6834 suppresses non-small cell lung cancer progression by destabilizing ANHAK and regulating miR-873-5p/TXNIP axis.
    Wang M; Ding X; Fang X; Xu J; Chen Y; Qian Y; Zhang J; Yu D; Zhang X; Ma X; Zhu T; Gu J; Zhang X
    Mol Cancer; 2024 Jun; 23(1):128. PubMed ID: 38890620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulated expression of TIPE3 inhibits malignant progression of non-small cell lung cancer via Wnt signaling.
    Zong Z; Tang G; Guo Y; Kong F
    Exp Cell Res; 2024 Jun; 439(2):114093. PubMed ID: 38759744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells.
    Zhang LL; Jiang XM; Huang MY; Feng ZL; Chen X; Wang Y; Li H; Li A; Lin LG; Lu JJ
    Phytomedicine; 2019 Jan; 52():32-39. PubMed ID: 30599910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.